肝硬化中的腹水和肝肾综合征：治疗的病理生理基础及当前管理 - Suppr

Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management.

作者信息

Arroyo Vicente, Colmenero Jordi

机构信息

Liver Unit, Institute of Digestive Diseases, Hospital Clínic, Villarroel, 170, University of Barcelona, 08036 Barcelona, Spain.

出版信息

J Hepatol. 2003;38 Suppl 1:S69-89. doi: 10.1016/s0168-8278(03)00007-2.

DOI:10.1016/s0168-8278(03)00007-2

PMID:12591187

Abstract

摘要

相似文献

Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management.

J Hepatol. 2003;38 Suppl 1:S69-89. doi: 10.1016/s0168-8278(03)00007-2.

Ascites and renal functional abnormalities in cirrhosis. Pathogenesis and treatment.

Baillieres Clin Gastroenterol. 1997 Jun;11(2):365-85. doi: 10.1016/s0950-3528(97)90045-2.

Is there still a need for albumin infusions to treat patients with liver disease?

Gut. 2000 May;46(5):588-90. doi: 10.1136/gut.46.5.588.

Ascites.

Clin Liver Dis. 2012 May;16(2):285-99. doi: 10.1016/j.cld.2012.03.004.

Ascites and hepatorenal syndrome during cirrhosis: two entities or the continuation of the same complication?

J Hepatol. 1999 Dec;31(6):1088-97. doi: 10.1016/s0168-8278(99)80324-9.

Ascites and hepatorenal syndrome: pathogenesis and treatment strategies.

Adv Intern Med. 1998;43:99-142.

[Physiopathology of refractory ascites and the hepatorenal syndrome].

Nefrologia. 2002;22 Suppl 5:41-6.

Hepatorenal syndrome and ascites--an introduction.

Liver. 1999;19(1 Suppl):5-14. doi: 10.1111/j.1478-3231.1999.tb00091.x.

Hepatorenal syndrome and ascites--questions and answers.

Liver. 1999;19(1 Suppl):15-74. doi: 10.1111/j.1478-3231.1999.tb00092.x.

Pathogenetic factors and clinical elements in ascites and hepatorenal syndrome during liver cirrhosis.

Ann Ital Med Int. 1999 Oct-Dec;14(4):264-84.

引用本文的文献

Mortality of Acute Kidney Injury in Cirrhosis: A Systematic Review and Meta-Analysis of Over 5 Million Patients Across Different Clinical Settings.

Aliment Pharmacol Ther. 2025 Feb;61(3):420-432. doi: 10.1111/apt.18426. Epub 2024 Dec 6.

Role of Transjugular Intrahepatic Portosystemic Shunt in the Liver Transplant Setting.

J Clin Med. 2024 Jan 21;13(2):600. doi: 10.3390/jcm13020600.

Insight into the hepatoprotective, hypolipidemic, and antidiabetic impacts of aliskiren in streptozotocin-induced diabetic liver disease in mice.

Diabetol Metab Syndr. 2022 Oct 31;14(1):163. doi: 10.1186/s13098-022-00935-5.

Research progress of spontaneous ruptured hepatocellular carcinoma: Systematic review and meta-analysis.

Front Oncol. 2022 Sep 29;12:973857. doi: 10.3389/fonc.2022.973857. eCollection 2022.

Hepatic lymphatic vascular system in health and disease.

J Hepatol. 2022 Jul;77(1):206-218. doi: 10.1016/j.jhep.2022.01.025. Epub 2022 Feb 11.

Hepatorenal syndrome in acute-on-chronic liver failure with acute kidney injury: more questions requiring discussion.

Gastroenterol Rep (Oxf). 2021 Sep 25;9(6):505-520. doi: 10.1093/gastro/goab040. eCollection 2021 Dec.

Evaluation of the Biomarkers HMGB1 and IL-6 as Predictors of Mortality in Cirrhotic Patients with Acute Kidney Injury.

Mediators Inflamm. 2020 Sep 25;2020:2867241. doi: 10.1155/2020/2867241. eCollection 2020.

Detoxification of bilirubin and bile acids with intermittent coupled plasmafiltration and adsorption in liver failure (HERCOLE study).

J Nephrol. 2021 Feb;34(1):77-88. doi: 10.1007/s40620-020-00799-w. Epub 2020 Jul 24.

Role of Terlipressin in Cirrhotic Patients with Ascites and without Hepatorenal Syndrome: A Systematic Review of Current Evidence.

Can J Gastroenterol Hepatol. 2020 Jun 22;2020:5106958. doi: 10.1155/2020/5106958. eCollection 2020.

Real-world effectiveness and safety of tolvaptan in liver cirrhosis patients with hepatic edema: results from a post-marketing surveillance study (START study).

J Gastroenterol. 2020 Aug;55(8):800-810. doi: 10.1007/s00535-020-01691-x. Epub 2020 May 9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management.

作者信息

机构信息

出版信息

相似文献

引用本文的文献